Literature DB >> 17183044

Best evidence topic report. Use of Heliox in the management of acute exacerbation of COPD.

Dhananjay Kumar1, Rajesh Kumar Saksena.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17183044      PMCID： PMC2658154          DOI： 10.1136/emj.2006.044370

Source DB:  PubMed          Journal:  Emerg Med J        ISSN： 1472-0205            Impact factor:   2.740


× No keyword cloud information.
  10 in total

1.  Use of heliox in patients with severe exacerbation of chronic obstructive pulmonary disease.

Authors:  P Gerbeaux; M Gainnier; A Boussuges; J Rakotonirina; P Nelh; D Torro; J M Arnal; P Jean
Journal:  Crit Care Med       Date:  2001-12       Impact factor: 7.598

2.  Helium-oxygen versus air-oxygen noninvasive pressure support in decompensated chronic obstructive disease: A prospective, multicenter study.

Authors:  Philippe Jolliet; Didier Tassaux; Jean Roeseler; Luc Burdet; Alain Broccard; William D'Hoore; François Borst; Marc Reynaert; Marie-Denise Schaller; Jean-Claude Chevrolet
Journal:  Crit Care Med       Date:  2003-03       Impact factor: 7.598

3.  Beneficial effects of helium:oxygen versus air:oxygen noninvasive pressure support in patients with decompensated chronic obstructive pulmonary disease.

Authors:  P Jolliet; D Tassaux; J M Thouret; J C Chevrolet
Journal:  Crit Care Med       Date:  1999-11       Impact factor: 7.598

4.  Randomized trial of the use of heliox as a driving gas for updraft nebulization of bronchodilators in the emergent treatment of acute exacerbations of chronic obstructive pulmonary disease.

Authors:  B P deBoisblanc; P DeBleiux; S Resweber; E E Fusco; W R Summer
Journal:  Crit Care Med       Date:  2000-09       Impact factor: 7.598

5.  Effects of helium-oxygen on intrinsic positive end-expiratory pressure in intubated and mechanically ventilated patients with severe chronic obstructive pulmonary disease.

Authors:  D Tassaux; P Jolliet; J Roeseler; J C Chevrolet
Journal:  Crit Care Med       Date:  2000-08       Impact factor: 7.598

6.  Heliox in the treatment of chronic obstructive pulmonary disease.

Authors:  R Andrews; M Lynch
Journal:  Emerg Med J       Date:  2004-11       Impact factor: 2.740

7.  Noninvasive ventilation with helium-oxygen in acute exacerbations of chronic obstructive pulmonary disease.

Authors:  S Jaber; R Fodil; A Carlucci; M Boussarsar; J Pigeot; F Lemaire; A Harf; F Lofaso; D Isabey; L Brochard
Journal:  Am J Respir Crit Care Med       Date:  2000-04       Impact factor: 21.405

8.  Helium/oxygen mixture reduces the work of breathing at the end of the weaning process in patients with severe chronic obstructive pulmonary disease.

Authors:  Jean-Luc Diehl; Alain Mercat; Emmanuel Guérot; Fethi Aïssa; Jean-Louis Teboul; Christian Richard; Jacques Labrousse
Journal:  Crit Care Med       Date:  2003-05       Impact factor: 7.598

Review 9.  Heliox for treatment of exacerbations of chronic obstructive pulmonary disease.

Authors:  G Rodrigo; C Pollack; C Rodrigo; B Rowe
Journal:  Cochrane Database Syst Rev       Date:  2002

10.  Helium-oxygen breathing in severe chronic obstructive pulmonary disease.

Authors:  D M Swidwa; H D Montenegro; M D Goldman; K R Lutchen; G M Saidel
Journal:  Chest       Date:  1985-06       Impact factor: 9.410
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.